1. Home
  2. Investing
  3. Stocks
  4. USA
  6. iTeos Therapeutics Inc (ITOS)
  7. Quote


iTeos Therapeutics Stock Price

-0.38 (-1.08%)
Upgrade to Real-Time
Regular Market
Volume 62,160
Bid Price 34.67
Ask Price 34.76
News -
Day High 36.03


52 Week Range


Day Low 34.00
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
iTeos Therapeutics Inc ITOS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.38 -1.08% 34.76 13:09:06
Open Price Low Price High Price Close Price Prev Close
35.67 34.00 36.03 35.14
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,546 62,160 $ 34.57 $ 2,149,046 - 17.43 - 47.61
Last Trade Time Type Quantity Stock Price Currency
13:09:15 1 $ 34.76 USD


Draw Mode:

iTeos Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.23B 35.27M 20.18M $ - $ - -0.49 28.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -1.90M 0.50%

more financials information »

iTeos Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ITOS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week38.0438.270434.0036.51239,183-3.28-8.62%
1 Month26.8438.7726.7033.05269,2857.9229.51%
3 Months28.8938.7725.4130.04190,4965.8720.32%
6 Months20.9338.7717.4326.16326,01013.8366.08%
1 Year28.2247.6117.4328.29284,2926.5423.18%
3 Years19.7047.6117.4327.86255,09915.0676.45%
5 Years19.7047.6117.4327.86255,09915.0676.45%

iTeos Therapeutics Description

ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody.

Your Recent History
iTeos Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.